Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|3|247-262

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.3, 2015-03, pp. : 247-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting Drug–Drug Interactions Involving Multiple Mechanisms Using Physiologically Based Pharmacokinetic Modeling: A Case Study With Ruxolitinib

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 177-185

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic (PBPK) Modeling in Children

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 40-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 542-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically‐based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to in vitro and physiologically‐based pharmacokinetic assessment of the drug–drug interaction potential of canagliflozin

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 392-393

John Wiley & Sons Inc

Access to resources Recommend Favorite